favipiravir

Term ID

CHEBI:134722

Synonyms

6-fluoro-3-hydroxy-2-pyrazinecarboxamide
6-fluoro-3-hydroxypyrazine-2-carboxamide
Areplivir
Avifavir
Avigan
fapilavir
Favilavir
Favipira
favipiravir
favipiravirum
T 705
T-705
T705

Definition

A member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan.

References

cas:259793-96-9
chemspider:431002
drugbank:DB12466
drugcentral:4887
kegg.drug:D09537
pmc:PMC7971419
pubmed:28105854
pubmed:28324644
pubmed:28465146
pubmed:28769016
pubmed:29289664
pubmed:29289666
pubmed:29369776
pubmed:29765101
pubmed:29936152
pubmed:29982696
pubmed:30715325
pubmed:30951731
pubmed:31195019
pubmed:31507197
pubmed:31673977
pubmed:32174453
pubmed:32553844
pubmed:32645335
pubmed:32834770
pubmed:32836314
pubmed:32863356
pubmed:33108587
pubmed:33232871
pubmed:33268271
pubmed:33418497
pubmed:33451007
pubmed:33457366
pubmed:33478340
pubmed:33494498
pubmed:33526596
pubmed:33649117
pubmed:33859168
reaxys:9697246
wikipedia.en:Favipiravir

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from favipiravir

Phenotype where environments contain favipiravir

Phenotype modified by environments containing favipiravir

Phenotype affecting favipiravir

Human Disease Model